Dead vaccine: Valneva boss advises not to wait for his vaccine
Created: 12/20/2021, 3:25 PM
By: Michelle Brey
While the booster vaccination campaign starts in Germany, others are still waiting for their first vaccination dose.
Vaccine skeptics in particular rely on dead vaccines.
A manufacturer is now warning.
Munich - Skepticism about the coronavirus vaccines remains.
Although many people in Germany have already received their booster vaccinations, the number of those who have not been vaccinated is high.
According to the Robert Koch Institute (RKI), 70 percent of the total population received two doses of vaccine
(as of December 16).
Many skeptics distrust the Covid-19 vaccines around Biontech, Moderna and Co. - despite testing, approval and recommendation.
They seem to prefer to wait for an alternative.
The focus here is on the protein-based vaccine from Novavax and the vaccine from Valneva, a so-called dead vaccine.
But is waiting the right way?
Ironically, the boss of the dead vaccine manufacturer Valneva now warned.
Dead vaccine Valneva: boss of the vaccine manufacturer warns explicitly - "I do not advise anyone ..."
"I do not advise anyone to wait for our vaccine," said Thomas Lingelbach, head of Valneva, to the newspaper
Spiegel
. He added that this was "ethically unacceptable". He himself received his booster vaccination with the corona vaccine from Biontech / Pfizer. Lingelbach made a call for vaccinations, he told the newspaper. "Get your vaccinations now", so the words of the Valneva boss.
Words that many people probably don't want to hear.
The VLA2001 vaccine from Valneva and Nuvaxovid from the US manufacturer Novavax are ultimately based - in contrast to previously approved vaccines - both on known vaccine methods.
Although the Novavax vaccine is often incorrectly declared as a dead vaccine.
It will take until 2022 for the two vaccines to come onto the market in the EU.
Valneva: Up to 60 million doses of the dead vaccine for the EU
In October, Valneva announced “positive” initial results from the phase 3 clinical trial with the vaccine.
The agent was more effective than the Astrazeneca vaccine, it said, and “generally well tolerated”.
The EU Commission had already concluded a supply contract with Valneva prior to approval.
As the commission announced just under a month ago, the agreement provides for the delivery of up to 60 million corona vaccine doses over the next two years, if the EMA actually allows the agent.
According to
information from the newspaper
Spiegel
, the vaccine manufacturer will receive a 30 percent advance payment.
"Significant amounts" of vaccine are already in stock, Lingelbach told the newspaper.
What is a dead vaccine?
A dead vaccine contains only killed viruses.
It cannot multiply in the body.
The dead vaccines include, for example, tetanus, whooping cough or diphtheria.
Corona dead vaccine Valneva: "Then we did our job"
However, speed is of the essence in the vaccination campaign.
Because in the middle of the delta wave, the new Coronavirus mutation Omikron is causing great concern.
Experts headed by virologist Sandra Ciesek have issued an urgent warning with a view to developments in Great Britain and Denmark.
For Ciesek “the flags are on red”.
However, Valneva's vaccine was produced for the original variant of the coronavirus.
However, Valneva is not too late, Lingelbach told
Spiegel.de
.
There are “a considerable number of people who do not want to be vaccinated with mRNA preparations”.
He also received daily letters from people who were waiting for the dead vaccine.
In any case, the vaccine manufacturer from Valneva seems to be hoping for big business.
Ultimately, Valneva's vaccine is supposed to make a “complementary” contribution to getting the coronavirus pandemic under control.
“If our product convinces more people than before to get vaccinated, it will help everyone.
Then we did our job, ”said the company's boss to the newspaper.
Most recently, studies on Novavax and Valneva also made people sit up and take notice.
How well do the two vaccines actually protect?
(mbr)
